Literature DB >> 2358455

Reconstitution of influenza virus RNA-nucleoprotein complexes structurally resembling native viral ribonucleoprotein cores.

K Yamanaka1, A Ishihama, K Nagata.   

Abstract

Reconstitution of influenza virus nucleoprotein (NP)-RNA complexes was performed with segment 8 RNA, which was synthesized in vitro from cDNA, and NP purified from virions. Under optimum conditions established using a filter binding assay and a gel retardation assay, NP was found to bind any RNA longer than 15 nucleotides. NP-RNA complexes formed at 30 degrees C are more resistant to high concentrations of NaCl than those formed at 0 degrees C. Treatment of NP with N-ethylmaleimide gave no effect on its RNA binding activity, whereas treatment with alkaline phosphatase enhanced its RNA binding activity. The newly developed "reverse-printing" method of RNase V1-treated complexes revealed that reconstituted NP-RNA complexes carry RNase V1-sensitive sites as do native ribonucleoprotein (RNP) cores (RNA polymerase-NP-RNA complexes), implying that RNA-NP complexes structurally similar to native RNP cores are reconstituted from isolated components.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle.

Authors:  J Martín-Benito; E Area; J Ortega; O Llorca; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Identification of amino acid residues of influenza virus nucleoprotein essential for RNA binding.

Authors:  D Elton; L Medcalf; K Bishop; D Harrison; P Digard
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.

Authors:  Kadir Turan; Masaki Mibayashi; Kenji Sugiyama; Shoko Saito; Akiko Numajiri; Kyosuke Nagata
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

4.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis.

Authors:  F Momose; C F Basler; R E O'Neill; A Iwamatsu; P Palese; K Nagata
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion production.

Authors:  Yuki Kobayashi; Bernadeta Dadonaite; Neeltje van Doremalen; Yoshiyuki Suzuki; Wendy S Barclay; Oliver G Pybus
Journal:  RNA Biol       Date:  2016-07-11       Impact factor: 4.652

7.  Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification.

Authors:  J Ortega; J Martín-Benito; T Zürcher; J M Valpuesta; J L Carrascosa; J Ortín
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Involvement of influenza virus PA subunit in assembly of functional RNA polymerase complexes.

Authors:  Atsushi Kawaguchi; Tadasuke Naito; Kyosuke Nagata
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

9.  Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain.

Authors:  M Kobayashi; T Toyoda; D M Adyshev; Y Azuma; A Ishihama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 10.  Teaching an Old Virus New Tricks: A Review on New Approaches to Study Age-Old Questions in Influenza Biology.

Authors:  Seema S Lakdawala; Nara Lee; Christopher B Brooke
Journal:  J Mol Biol       Date:  2019-04-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.